Increased Platelet-to-Lymphocyte Ratio is an Independent Predictor of Hemorrhagic Transformation and In-Hospital Mortality Among Acute Ischemic Stroke with Large-Artery Atherosclerosis Patients

References

• Adams HP Jr, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in acute stroke treatment. Stroke. 1993;24(1):35–41.
   PubMed Web of Science ®Google Scholar
• Rovira A, Grive E, Rovira A, Alvarez-Sabin J. Distribution territories and causative mechanisms of ischemic stroke. Eur Radiol. 2005;15:416–426.
   PubMed Web of Science ®Google Scholar
• Von Kummer R, Broderick JP, Campbell BCV, et al. The Heidelberg bleeding classification: classification of bleeding events after ischemic stroke and reperfusion therapy. Stroke. 2015;46(10):2981–2986. doi:10.1161/STROKEAHA.115.010049
   PubMed Web of Science ®Google Scholar
• Jickling GC, Liu D, Stamova B, et al. Hemorrhagic transformation after ischemic stroke in animals and humans. J Cereb Blood Flow Metab. 2014;34:185–199. doi:10.1038/jcbfm.2013.203
   PubMed Web of Science ®Google Scholar
• Lu GF, He QW, Shen Y, Cao F. Potential biomarkers for predicting hemorrhagic transformation of ischemic stroke. Int J Neurosci. 2018;128:179–189. doi:10.1080/00207454.2017.1349766
   Web of Science ®Google Scholar
• Lee SJ, Lee DG. Distribution of atherosclerotic stenosis determining early neurologic deterioration in acute ischemic stroke. PloS One. 2017;12(9):e0185314. doi:10.1371/journal.pone.0185314
   PubMed Web of Science ®Google Scholar
• Wolf D, Ley K. Immunity and inflammation in atherosclerosis. Circ Res. 2019;124(2):315–327. doi:10.1161/CIRCRESAHA.118.313591
   PubMed Web of Science ®Google Scholar
• Schaftenaar F, Frodermann V, Kuiper J, Lutgens E. Atherosclerosis: the interplay between lipids and immune cells. Curr Opin Lipidol. 2016;27(3):209–215.
   PubMed Web of Science ®Google Scholar
• Song QH, Pan RS, Jin YX, et al. Lymphocyte-to-monocyte ratio and risk of hemorrhagic transformation in patients with acute ischemic stroke. Neurol Sci. 2020;41(9):2511–2520. doi:10.1007/s10072-020-04355-z
   PubMed Web of Science ®Google Scholar
• He WW, Ruan YT, Yuan CX, et al. High neutrophil-to-platelet ratio is associated with hemorrhagic transformation in patients with acute ischemic stroke. Front Neurol. 2019;10:1310. doi:10.3389/fneur.2019.01310
   PubMed Web of Science ®Google Scholar
• Zhang WB, Zeng YY, Wang F, Cheng L, Tang WJ, Wang XQ. A high neutrophil-to-lymphocyte ratio predicts hemorrhagic transformation of large atherosclerotic infarction in patients with acute ischemic stroke. Aging. 2020;12(3):2428–2439. doi:10.18632/aging.102752
   PubMedGoogle Scholar
• Zhang RR, Wu XD, Hu WJ, et al. Neutrophil‐to‐lymphocyte ratio predicts hemorrhagic transformation in ischemic stroke: a meta‐analysis. Brain Behav. 2019;9(9):e01382. doi:10.1002/brb3.1382
   PubMed Web of Science ®Google Scholar
• Song QH, Li YS, Wang YN, Wei CC, Liu JF, Liu M. Increased neutrophil-to-lymphocyte ratios are associated with greater risk of hemorrhagic transformation in patients with acute ischemic stroke. Curr Neurovasc Res. 2018;15(4):326–335. doi:10.2174/1567202616666181204122457
   PubMed Web of Science ®Google Scholar
• Gong PY, Xie Y, Jiang T, et al. Neutrophil-lymphocyte ratio predicts post-thrombolysis early neurological deterioration in acute ischemic stroke patients. Brain Behav. 2019;9(10):e01426. doi:10.1002/brb3.1426
   PubMed Web of Science ®Google Scholar
• Duan ZH, Wang HM, Wang Z, et al. Neutrophil-lymphocyte ratio predicts functional and safety outcomes after endovascular treatment for acute ischemic stroke. Cerebrovasc Dis. 2018;45(5–6):221–227. doi:10.1159/000489401
   PubMed Web of Science ®Google Scholar
• Brooks SD, Spears C, Cummings C, et al. Admission neutrophil‐lymphocyte ratio predicts 90 day outcome after endovascular stroke therapy. J Neurointerv Surg. 2014;6(8):578–583. doi:10.1136/neurintsurg-2013-010780
   PubMed Web of Science ®Google Scholar
• Xu JH, He XW, Li Q, et al. Higher platelet-to-lymphocyte ratio is associated with worse outcomes after intravenous thrombolysis in acute ischaemic stroke. Front Neurol. 2019;10:1192. doi:10.3389/fneur.2019.01192
   PubMed Web of Science ®Google Scholar
• Maimaiti A, Li Y, Wang YT, et al. Association of platelet-to-lymphocyte count ratio with myocardial reperfusion and major adverse events in patients with acute myocardial infarction: a two-center retrospective cohort study. BMJ Open. 2019;9(9):e025628. doi:10.1136/bmjopen-2018-025628
   PubMed Web of Science ®Google Scholar
• Zhang YF, Jiang L, Yang P, Zhang YZ. Comparison of lymphocyte count, neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in predicting the severity and the clinical outcomes of acute cerebral infarction patients. Clin Lab. 2019;65(7). doi:10.7754/Clin.Lab.2019.190102
   Web of Science ®Google Scholar
• Huang GQ, Chen HJ, Wang QZ, et al. High platelet-to-lymphocyte ratio are associated with post-stroke depression. J Affect Disord. 2019;246:105–111. doi:10.1016/j.jad.2018.12.012
   PubMed Web of Science ®Google Scholar
• Hatano S. Experience from a multicenter stroke register: a preliminary report. Bull World Health Organ. 1976;54(5):541–553.
   PubMed Web of Science ®Google Scholar
• de Los Rios la Rosa F, Khoury J, Kissela BM, et al. Eligibility for intravenous recombinant tissue-type plasminogen activator within a population: the effect of the European Cooperative Acute Stroke Study (ECASS) III trial. Stroke. 2012;43(6):1591–1595. doi:10.1161/STROKEAHA.111.645986
   PubMed Web of Science ®Google Scholar
• Yuksel M, Yildiz A, Oylumlu M, et al. The association between platelet/lymphocyte ratio and coronary artery disease severity. Anatol J Cardiol. 2015;15:640–647. doi:10.5152/akd.2014.5565
   PubMed Web of Science ®Google Scholar
• Rust R, Grönnert L, Schwab ME. Inflammation after stroke: a local rather than systemic response? Trends Neurosci. 2018;41(12):877–879. doi:10.1016/j.tins.2018.09.011
   PubMed Web of Science ®Google Scholar
• Xu XR, Zhang D, Oswald BE, et al. Platelets are versatile cells: new discoveries in hemostasis, thrombosis, immune responses, tumor metastasis and beyond. Crit Rev Clin Lab Sci. 2016;53:409–430. doi:10.1080/10408363.2016.1200008
   PubMed Web of Science ®Google Scholar
• Mercuri M, Cinffetti G, Lombardini R, Neri C, Robinson M. Do leukocytes have a role in the cerebrovascular no-reflow phenomenon? J Neurol Neurosurg Psychiatry. 1990;53(6):536.
   PubMed Web of Science ®Google Scholar
• Arumugam TV, Granger DN, Mattson MP. Stroke and T-cells. Neuromolecular Med. 2015;7(3):229–242. doi:10.1385/NMM:7:3:229
   Web of Science ®Google Scholar
• Huang J, Upadhyay UM, Tamargo RJ. Inflammation in stroke and focal cerebral ischemia. Surg Neurol. 2006;66(3):232–245.
   PubMedGoogle Scholar
• Perera MN, Ma HK, Arakawa S, et al. Inflammation following stroke. J Clin Neurosci. 2006;13(1):1–8. doi:10.1016/j.jocn.2005.07.005
   PubMed Web of Science ®Google Scholar
• Jin R, Yang G, Li G. Molecular insights and therapeutic targets for blood-brain barrier disruption in ischemic stroke: critical role of matrix metalloproteinases and tissue-type plasminogen activator. Neurobiol Dis. 2010;38:376–385. doi:10.1016/j.nbd.2010.03.008
   PubMed Web of Science ®Google Scholar
• Turner RJ, Sharp FR. Implications of MMP9 for blood brain barrier disruption and hemorrhagic transformation following ischemic stroke. Front Cell Neurosci. 2016;10:56. doi:10.3389/fncel.2016.00056
   PubMed Web of Science ®Google Scholar
• Macrez R, Ali C, Toutirais O, et al. Stroke and the immune system: from pathophysiology to new therapeutic strategies. Lancet Neurol. 2011;10(5):471–480. doi:10.1016/S1474-4422(11)70066-7
   PubMed Web of Science ®Google Scholar
• Salas-Perdomo A, Miró-Mur F, Urra X, et al. T cells prevent hemorrhagic transformation in ischemic stroke by P-selectin binding. Arterioscler Thromb Vasc Biol. 2018;38(8):1761–1771. doi:10.1161/ATVBAHA.118.311284
   PubMed Web of Science ®Google Scholar
• Yip HK, Chen SS, Liu JS, et al. Serial changes in platelet activation in patients after ischemic stroke: role of pharmacodynamic modulation. Stroke. 2004;35(7):1683–1687. doi:10.1161/01.STR.0000131658.80951.c3
   PubMed Web of Science ®Google Scholar
• Fateh-Moghadam S, Htun P, Tomandl B, et al. Hyperresponsiveness of platelets in ischemic stroke. Thromb Haemost. 2007;97(6):974–978. doi:10.1160/TH06-12-0725
   PubMed Web of Science ®Google Scholar
• Marquardt L, Ruf A, Mansmann U, et al. Course of platelet activation markers after ischemic stroke. Stroke. 2002;33(11):2570–2574. doi:10.1161/01.STR.0000034398.34938.20
   PubMed Web of Science ®Google Scholar
• Yilmaz G, Arumugam TV, Stokes KY, Granger DN. Role of T lymphocytes and interferon-gamma in ischemic stroke. Circulation. 2006;113(17):2105–2112. doi:10.1161/CIRCULATIONAHA.105.593046
   PubMed Web of Science ®Google Scholar
• Gorelick PB, Wong KS, Bae HJ, Pandey DK. Large artery intracranial occlusive disease: a large worldwide burden but a relatively neglected frontier. Stroke. 2008;39:2396–2399. doi:10.1161/STROKEAHA.107.505776
   PubMed Web of Science ®Google Scholar
• Bang OY. Intracranial atherosclerosis: current understanding and perspectives. J Stroke. 2014;16(1):27. doi:10.5853/jos.2014.16.1.27
   PubMed Web of Science ®Google Scholar
• Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol. 2010;9(7):689–701. doi:10.1016/S1474-4422(10)70104-6
   PubMed Web of Science ®Google Scholar
• Yang Y, Han YF, Sun WD, Zhang YB. Increased systemic immune-inflammation index predicts hemorrhagic transformation in anterior circulation acute ischemic stroke due to large-artery atherosclerotic. Int J Neurosci. 2021;Jul 22:1–7. doi:10.1080/00207454.2021.1953021
   Web of Science ®Google Scholar
• Yang M, Pan Y, Li Z, et al. Platelet count predicts adverse clinical outcomes after ischemic stroke or TIA: subgroup analysis of CNSR II. Front Neurol. 2019;10:370. doi:10.3389/fneur.2019.00370
   PubMed Web of Science ®Google Scholar
• Zierath D, Tanzi P, Shibata D, Becker KJ. Cortisol is more important than metanephrines in driving changes in leukocyte counts after stroke. J Stroke Cerebrovasc Dis. 2018;27:555–562. doi:10.1016/j.jstrokecerebrovasdis.2017.09.048
   PubMed Web of Science ®Google Scholar
• Cetin EHO, Cetin MS, Aras D, et al. Platelet to lymphocyte ratio as a prognostic marker of in-hospital and long term major adverse cardiovascular events in ST-segment elevation myocardial infarction. Angiology. 2016;67:336–345. doi:10.1177/0003319715591751
   PubMed Web of Science ®Google Scholar
• Bodi V, Sanchis J, Nunez J, et al. Post-reperfusion lymphopenia and microvascular obstruction in ST-segment elevation acute myocardial infarction. Rev Esp Cardiol. 2009;62:1109–1117.
   PubMed Web of Science ®Google Scholar